Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · IEX Real-Time Price · USD
-0.26 (-4.26%)
At close: Jul 12, 2024, 4:00 PM
-0.09 (-1.54%)
After-hours: Jul 12, 2024, 7:46 PM EDT

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $28.01M in the twelve months ending March 31, 2024, with 198.84% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.43M with 7.84% year-over-year growth. In the year 2023, Zevra Therapeutics had annual revenue of $27.46M with 170.26% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
244.84M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202327.46M17.30M170.26%
Dec 31, 202210.16M-18.49M-64.53%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Butterfly Network 68.08M
Sanara MedTech 68.00M
Aquestive Therapeutics 51.50M
AVITA Medical 51.50M
Utah Medical Products 49.04M
Revenue Rankings